Mangalam Drugs and Organics Limited, the company engaged in the business of manufacturing various Active Pharmaceutical Ingredients (APIs), has announced the commissioning of a new intermediate manufacturing facility at Unit 1 located in Vapi, Gujarat.

This intermediate is an import substitute and an important raw material, which the company was importing from China. The company is the first company in the organized sector to manufacture this in-house. This will enable Mangalam to reduce its reliability on Chinese imports for this product and also help to maintain an uninterrupted supply chain to a great extent.

This being a multi-product manufacturing facility, it will also support production of a few more intermediates that are presently being imported from China, thus making us self-sufficient to a great extent.
Mangalam Drugs & Organics Limited commenced its manufacturing of Active Pharmaceutical Ingredients (APIs) and Intermediates at VAPI, Gujarat in 1977.

It has a multi-product manufacturing facility in two locations, and an in-house Research & Development laboratory recognized by the Department of Scientific & Industrial Research, Delhi Govt. of India. Over the last three decades, Mangalam has acquired a worldwide reputation as a single stop destination for frontline anti-malaria.